ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Chemtura has reached a definitive agreement to acquire the bromine assets of India’s Solaris ChemTech Industries for $142 million. The deal, expected to close by the end of 2012, includes two bromine and bromine derivatives manufacturing sites and an R&D center in the state of Gujarat. About 300 workers will transfer to Chemtura. Solaris’ chlor-alkali and phosphoric acid assets are not included in the deal. Chemtura says the acquisition will expand its existing footprint in Asia. About a year ago, Chemtura formed an alliance in bromine and brominated derivatives with Chennai, India-based Achean Group.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter